Influence of chemical permeation enhancers on transdermal permeation of alfuzosin: an investigation using response surface modeling

References

• Prausnitz MR, Mitragotri S, Langer R. (2004). Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov, 3:115–24.
   PubMed Web of Science ®Google Scholar
• Williams AC, Barry BW. (2004). Penetration enhancers. Adv Drug Dev Rev, 56:603–18.
   PubMed Web of Science ®Google Scholar
• Mc Keage K, Plosker GL. (2002). Alfuzosin: A review of the therapeutic use of the prolonged-release formulation given once daily in the management of benign prostatic hyperplasia. Drugs, 62:633–53.
   PubMed Web of Science ®Google Scholar
• Roehrborn CG. (2001). Alfuzosin: Overview of pharmacokinetics, safety, and efficacy of a clinically uroselective alphablocker. Urology, 58:55–63.
   PubMed Web of Science ®Google Scholar
• Pattnaik S, Swain K, Choudhury P, Acharya PK, Mallick S. (2009). Alfuzosin hydrochloride transdermal films: Evaluation of physicochemical, in vitro human cadaver skin permeation and thermodynamic parameters. Int Brazil J Urol, 35:716–29.
   PubMed Web of Science ®Google Scholar
• Melas VB. (2006). Functional approach to optimal experimental design. New York: Springer, 197–228.
   Google Scholar
• Eriksson L, Johansson E, Wikstrom C. (1998). Mixture design: Design generation, PLS analysis and model usage. Chemomet Intell Lab Syst, 43:1–24.
   Web of Science ®Google Scholar
• Bodea A, Leucuta SE. (1997). Optimization of hydrophilic matrix tablets using a D-optimal design. Int J Pharm, 153:247–55.
   Web of Science ®Google Scholar
• Cornell JA. (1990). Designs models and the analysis of mixture data. 2nd ed. New York: John Wiley, 188–236.
   Google Scholar
• Kligman AM, Christophers E. (1963). Preparation of isolated sheets of human stratum corneum. Arch Dermatol, 88:702–5.
   PubMed Web of Science ®Google Scholar
• Akomeah F, Nazir T, Martin GP, Brown MB. (2004). Effect of heat on the percutaneous absorption and skin retention of three model penetrants. Eur J Pharm Sci, 21:337–45.
   PubMed Web of Science ®Google Scholar
• Kumar MG, Lin S. (2008). Transdermal iontophoresis: Impact on skin integrity as evaluated by various methods. Crit Rev Ther Drug Carrier Syst, 25:381–401.
   PubMed Web of Science ®Google Scholar
• Sherertz EF, Sloan KB, McTiernan RG. (1987). Effect of skin pretreatment with vehicle alone or drug in vehicle on flux of a subsequently applied drug: Results of hairless mouse skin and diffusion cell studies. J Invest Dermatol, 89:249–52.
   PubMed Web of Science ®Google Scholar
• Costa P, Lobo J. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm, 13:123–33.
   Web of Science ®Google Scholar
• Guy RH, Hadgraft J, Hinz RS, Roskos KV, Bucks DAW. (1987). In vivo evaluations of transdermal drug delivery. In: Chien YW, ed. Transdermal controlled systemic medications. New York: Marcel Dekker Inc., 179–224.
   Google Scholar
• Kim MK, Zhao H, Lee CH, Kim DD. (2001). Formulation of a reservoir-type testosterone transdermal delivery system. Int J Pharm, 219:51–9.
   PubMed Web of Science ®Google Scholar
• Pattnaik S, Swain K, Mallick S. (2009). Influence of polymeric system and loading dose on drug release from alfuzosin hydrochloride transdermal films. Lat Am J Pharm, 28:62–9.
   Web of Science ®Google Scholar
• Swain K, Pattnaik S, Mallick S, Chowdary KA. (2009). Influence of hydroxypropyl methylcellulose on drug release pattern of a gastroretentive floating drug delivery system using a 32 full factorial design. Pharm Dev Technol, 14:193–8.
   PubMed Web of Science ®Google Scholar
• Swain K, Pattnaik S, Sahu SC, Patnaik KK, Mallick S. (2010). Drug in adhesive type transdermal matrix systems of ondansetron hydrochloride: Optimization of permeation pattern using response surface methodology. J Drug Target, 18:106–14.
   PubMed Web of Science ®Google Scholar
• Lewis GA, Mathieu D, Phan-Tan-Luu R. (1999). Response surface methodology. In: Pharmaceutical experimental design. New York: Marcel Dekker Inc., 185–246.
   Google Scholar
• Choi A, Gang H, Chun I, Gwak H. (2008). The effects of fatty acids in propylene glycol on the percutaneous absorption of alendronate across the excised hairless mouse skin. Int J Pharm, 357:126–31.
   PubMed Web of Science ®Google Scholar
• Ponec M, Haverkort M, Soei YL, Kempenaar J, Brussee H, Bodde HE. (1989). Toxicity screening of n-alkylazacycloheptan-2-one derivatives in cultured human skin cells: Structure–toxicity relationships. J Pharm Sci, 78:738–41.
   PubMed Web of Science ®Google Scholar
• Kadir R, Ponec M, Tiemessen HLGM, Junginger HE, Bodde HE. (1993). Oleyl surfactants as skin penetration enhancers: Effects on human stratum corneum permeability and in vitro toxicity to cultured human skin cells. In: Walters KA, Hadgraft J, eds. Pharmaceutical skin penetration enhancement, vol. 59. New York: Marcel Dekker, Inc., 215–28.
   Google Scholar
• Barry BW. (1987). Mode of action of penetration enhancers in human skin. J Control Release, 6:85–97.
   Google Scholar
• Cooper ER. (1984). Increased skin permeability for lipophilic molecules. J Pharm Sci, 73:1153–6.
   PubMed Web of Science ®Google Scholar
• Cooper ER, Merritt EW, Smith RL. (1985). Effect of fatty acids and alcohols on the penetration of acyclovir across human skin in vitro. J Pharm Sci, 74:688–9.
   PubMed Web of Science ®Google Scholar
• Aungst BJ, Rogers NJ, Shefter E. (1986). Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int J Pharm, 33:225–34.
   Web of Science ®Google Scholar
• Nomura H, Fusao K, Sugimoto Y, Miyashita Y, Dohi M, Kato Y. (1990). Percutaneous absorption of indomethacin from mixtures of fatty alcohol and propylene glycol (FAPG base) through rat skin: Effects of oleic acid added to FAPG base. Chem Pharm Bull, 38:1421–4.
   PubMed Web of Science ®Google Scholar
• Myers RH, Montgomery DC. (2002). Response surface methodology: Process and product optimization using designed experiments. New York: John Wiley, 273–86.
   Google Scholar
• Emami J (2006). In vitro–in vivo correlation: From theory to applications. J Pharm Pharm Sci, 9:31–51.
   Google Scholar